| scholarly article | Q13442814 |
| P50 | author | Shihuan Kuang | Q55807373 |
| P2093 | author name string | Bin Zhang | |
| Xuelian Zhang | |||
| Jingyi Zhang | |||
| Xiaobo Sun | |||
| Guibo Sun | |||
| Chenyang Zhang | |||
| Jingxue Ye | |||
| P2860 | cites work | Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation | Q24290777 |
| Chemistry and biology of reactive oxygen species in signaling or stress responses | Q24633682 | ||
| Arkadia-Smad7-mediated positive regulation of TGF-beta signaling in a rat model of tubulointerstitial fibrosis | Q28568730 | ||
| The expression of Wnt4 is regulated by estrogen via an estrogen receptor alpha-dependent pathway in rat pituitary growth hormone-producing cells | Q28573258 | ||
| Estrogen inhibits transforming growth factor beta signaling by promoting Smad2/3 degradation | Q33825125 | ||
| Expansion of human cardiac stem cells in physiological oxygen improves cell production efficiency and potency for myocardial repair | Q34410262 | ||
| Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells | Q34553671 | ||
| Advanced glycation endproducts: a biomarker for age as an outcome predictor after cardiac surgery? | Q34625742 | ||
| Oxidative stress and diabetic cardiomyopathy: a brief review | Q34817248 | ||
| Estrogen receptor α mediates the effects of notoginsenoside R1 on endotoxin-induced inflammatory and apoptotic responses in H9c2 cardiomyocytes | Q35628334 | ||
| Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice | Q35883067 | ||
| Correlation between advanced glycation end-products and the expression of fatty inflammatory factors in type II diabetic cardiomyopathy | Q36402281 | ||
| Cardioprotective effects of Notoginsenoside R1 against ischemia/reperfusion injuries by regulating oxidative stress- and endoplasmic reticulum stress- related signaling pathways | Q36591543 | ||
| miR-29c is implicated in the cardioprotective activity of Panax notoginseng saponins against isoproterenol-induced myocardial fibrogenesis. | Q50990193 | ||
| Estrogenic compound attenuates angiotensin II-induced vascular smooth muscle cell proliferation through interaction between LKB1 and estrogen receptor α. | Q51465837 | ||
| Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. | Q52944542 | ||
| Tachycardia of atrial myocytes induces collagen expression in atrial fibroblasts through transforming growth factor β1. | Q53285086 | ||
| Estrogen receptor-beta mediates male-female differences in the development of pressure overload hypertrophy. | Q53634437 | ||
| Potential role of cyanidin 3-glucoside (C3G) in diabetic cardiomyopathy in diabetic rats: An in vivo approach. | Q54114695 | ||
| MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway. | Q54186666 | ||
| Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor α. | Q54293574 | ||
| Diabetes, a New Mutation in the Mouse | Q72798788 | ||
| Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice | Q73127304 | ||
| Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy | Q79257400 | ||
| Notoginsenoside R1 inhibits TNF-alpha-induced fibronectin production in smooth muscle cells via the ROS/ERK pathway | Q83188816 | ||
| Allopurinol attenuates left ventricular dysfunction in rats with early stages of streptozotocin-induced diabetes | Q83569472 | ||
| Advanced glycation end-products impair Na⁺/K⁺-ATPase activity in diabetic cardiomyopathy: role of the adenosine monophosphate-activated protein kinase/sirtuin 1 pathway | Q86954415 | ||
| Notoginsenoside R1 attenuates cardiac dysfunction in endotoxemic mice: an insight into oestrogen receptor activation and PI3K/Akt signalling | Q36709261 | ||
| Methylglyoxal-Induced Endothelial Cell Loss and Inflammation Contribute to the Development of Diabetic Cardiomyopathy | Q36930808 | ||
| Skeletal muscle action of estrogen receptor α is critical for the maintenance of mitochondrial function and metabolic homeostasis in females | Q37069670 | ||
| Broccoli sprout extract prevents diabetic cardiomyopathy via Nrf2 activation in db/db T2DM mice | Q37125260 | ||
| Metformin exerts glucose-lowering action in high-fat fed mice via attenuating endotoxemia and enhancing insulin signaling | Q37151577 | ||
| High Glucose-Induced Oxidative Stress Mediates Apoptosis and Extracellular Matrix Metabolic Imbalances Possibly via p38 MAPK Activation in Rat Nucleus Pulposus Cells | Q37231720 | ||
| Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer | Q37667038 | ||
| Myricitrin Alleviates Oxidative Stress-induced Inflammation and Apoptosis and Protects Mice against Diabetic Cardiomyopathy. | Q37695422 | ||
| Inhibition of Smurf2 translation by miR-322/503 modulates TGF-β/Smad2 signaling and intestinal epithelial homeostasis | Q37696868 | ||
| Reactive oxygen species (ROS)--a family of fate deciding molecules pivotal in constructive inflammation and wound healing. | Q38046135 | ||
| Inhibition of human colorectal cancer metastasis by notoginsenoside R1, an important compound from Panax notoginseng | Q38731263 | ||
| Suppression of antioxidant Nrf-2 and downstream pathway in H9c2 cells by advanced glycation end products (AGEs) via ERK phosphorylation | Q38849059 | ||
| RNF11 sequestration of the E3 ligase SMURF2 on membranes antagonizes SMAD7 down-regulation of transforming growth factor β signaling | Q38908304 | ||
| Notoginsenoside R1 attenuates amyloid-β-induced damage in neurons by inhibiting reactive oxygen species and modulating MAPK activation | Q38979901 | ||
| Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis | Q39056962 | ||
| Overexpression of Smad ubiquitin regulatory factor 2 suppresses transforming growth factor-β mediated liver fibrosis | Q39342955 | ||
| Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane | Q39740320 | ||
| Mangiferin suppressed advanced glycation end products (AGEs) through NF-κB deactivation and displayed anti-inflammatory effects in streptozotocin and high fat diet-diabetic cardiomyopathy rats | Q40123261 | ||
| The rising global burden of diabetes and its complications: estimates and projections to the year 2010. | Q40909593 | ||
| Attenuation of TNF-α-Induced Inflammatory Injury in Endothelial Cells by Ginsenoside Rb1 via Inhibiting NF-κB, JNK and p38 Signaling Pathways | Q41220857 | ||
| Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NFκB Pathway Suppression. | Q41430394 | ||
| Mitochondrial oxidative stress promotes atrial fibrillation | Q41458404 | ||
| Butein provides neuroprotective and anti-neuroinflammatory effects through Nrf2/ARE-dependent haem oxygenase 1 expression by activating the PI3K/Akt pathway | Q41635353 | ||
| Advanced glycation end products and lipopolysaccharides stimulate interleukin-6 secretion via the RAGE/TLR4-NF-κB-ROS pathways and resveratrol attenuates these inflammatory responses in mouse macrophages | Q42675815 | ||
| Chrysin, a PPAR-γ agonist improves myocardial injury in diabetic rats through inhibiting AGE-RAGE mediated oxidative stress and inflammation | Q42698984 | ||
| Suppression of NADPH oxidase- and mitochondrion-derived superoxide by Notoginsenoside R1 protects against cerebral ischemia-reperfusion injury through estrogen receptor-dependent activation of Akt/Nrf2 pathways | Q42706056 | ||
| Cardiac function and metabolism in Type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-alpha activator | Q44103914 | ||
| Panax notoginseng Attenuates the Infarct Volume in Rat Ischemic Brain and the Inflammatory Response of Microglia | Q46079113 | ||
| Methylglyoxal-derived hydroimidazolone-1 evokes inflammatory reactions in endothelial cells via an interaction with receptor for advanced glycation end products | Q46347438 | ||
| Nrf2 Activation as a Protective Feedback to Limit Cell Death in High Glucose-Exposed Cardiomyocytes | Q46458284 | ||
| Estrogen Signals Through Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease. | Q46486492 | ||
| Advanced glycation end products inhibit testosterone secretion by rat Leydig cells by inducing oxidative stress and endoplasmic reticulum stress | Q46530953 | ||
| Exogenous hydrogen sulphide ameliorates diabetic cardiomyopathy in rats by reversing disordered calcium-handling system in sarcoplasmic reticulum | Q46581242 | ||
| Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice | Q46702107 | ||
| Advanced glycation end products-induced chondrocyte apoptosis through mitochondrial dysfunction in cultured rabbit chondrocyte | Q46830048 | ||
| Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells | Q46949363 | ||
| Hepatocyte estrogen receptor alpha mediates estrogen action to promote reverse cholesterol transport during Western-type diet feeding | Q47553873 | ||
| The protective effects of 17beta-estradiol against ischemia-reperfusion injury and its effect on pacing postconditioning protection to the heart | Q49030574 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diabetic cardiomyopathy | Q5270132 |
| cardiomyopathy | Q847583 | ||
| P304 | page(s) | 1227 | |
| P577 | publication date | 2018-11-02 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | Notoginsenoside R1 Protects Against Diabetic Cardiomyopathy Through Activating Estrogen Receptor α and Its Downstream Signaling | |
| P478 | volume | 9 |
| Q89964211 | Distinct Types of Cell Death and the Implication in Diabetic Cardiomyopathy |
| Q89906820 | Focus on Notoginsenoside R1 in Metabolism and Prevention Against Human Diseases |
| Q61798175 | Notoginsenoside R1 Protects db/db Mice against Diabetic Nephropathy via Upregulation of Nrf2-Mediated HO-1 Expression |
| Q92856733 | Specific Inhibition of CYP4A Alleviates Myocardial Oxidative Stress and Apoptosis Induced by Advanced Glycation End-Products |
Search more.